✦ LIBER ✦

Outcome of Surgical Resection as a First Line Therapy in T3 Non-small Cell Lung Cancer Patients

✍ Scribed by Takenaka, Tomoyoshi; Katsura, Masakazu; Shikada, Yasunori; Takeo, Sadanori

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab as First-Line Therapy in Adv

✍ Dr. Denis Leonardo Fontes Jardim, Débora de Melo Gagliato… 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 163 KB

Gemcitabine and cisplatin as a first lin

✍ Pes̆ek, M; Eliasová, B; C̆ertíková, G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Gefitinib as first-line, compassionate u

✍ Argiris, Athanassios; Mittal, Namrata 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Treatment of Surgically Resectable Non–S

✍ Benjamin E. Haithcock; Thomas E. Stinchcombe; Mark A. Socinski 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 103 KB

Novel histological determinants of outco

✍ Colosimo, M.L; Kevat, D; Clarke, L; Duhig, E; Abraham, R; Musgrave, K; Matar, K; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Surgical outcomes of N2 and T3-4 non-sma

✍ Watanabe, Yoh 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 85 KB